1. Utilization of NGS technologies to investigate transcriptomic and epigenomic mechanisms in trastuzumab resistance
   Miguel Nava et al, 2019, Scientific Reports CrossRef
2. ZBTB7A as a therapeutic target for cancer
   Ying Zhou et al, 2024, Biochemical and Biophysical Research Communications CrossRef
3. mmu-miRNA-342-3p promotes hepatic stellate cell activation and hepatic fibrosis induced by Echinococcus multilocularis infection via targeting Zbtb7a
   Shanling Cao et al, 2023, PLOS Neglected Tropical Diseases CrossRef
4. Obesity-Induced Upregulation of ZBTB7A Promotes Lipid Accumulation through SREBP1
   Jing-ping Zhou et al, 2020, BioMed Research International CrossRef
5. Role of ZBTB7A zinc finger in tumorigenesis and metastasis
   Atul Kumar Singh et al, 2021, Molecular Biology Reports CrossRef
6. High‐resolution transcriptomic and epigenetic profiling identifies novel regulators of COPD
   Uwe Schwartz et al, 2023, The EMBO Journal CrossRef
7. ZBTB7A as a novel vulnerability in neuroendocrine prostate cancer
   Song Yi Bae et al, 2023, Frontiers in Endocrinology CrossRef
8. BTB protein family and human breast cancer: signaling pathways and clinical progress
   Haorui Zhang et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
9. Impact of ZBTB7A hypomethylation and expression patterns on treatment response to hydroxyurea
   Vasiliki Chondrou et al, 2018, Human Genomics CrossRef
10. Heterozygous variants in ZBTB7A cause a neurodevelopmental disorder associated with symptomatic overgrowth of pharyngeal lymphoid tissue, macrocephaly, and elevated fetal hemoglobin
    Charlotte von der Lippe et al, 2022, American Journal of Medical Genetics Part A CrossRef